Primary Recipient

OREGON HEALTH & SCIENCE UNIVERSITY

Amount

$2,998,501.00

Award Date

9/30/2009

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

The OHSU Knight Cancer Institute (Knight) has a history of running high-impact Phase I clinical trials, including imatinib, calcitriol and most recently MDV-3100. As part of the Phase I studies, Knight investigators have developed pharmacodynamic and mol